126 related articles for article (PubMed ID: 14984512)
1. Spinal cord compression in monoclonal gammopathy of undetermined significance.
Bernardeschi P; Fiorentini G; Dentico P; Rossi S
Br J Haematol; 2004 Feb; 124(4):561-2. PubMed ID: 14984512
[No Abstract] [Full Text] [Related]
2. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Kristinsson SY; Björkholm M; Schulman S; Landgren O
Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
[TBL] [Abstract][Full Text] [Related]
3. On the "significance" of monoclonal gammopathy of undetermined significance.
Bladé J
Mayo Clin Proc; 2004 Jul; 79(7):855-6. PubMed ID: 15244379
[No Abstract] [Full Text] [Related]
4. [CME: Multiple Myeloma - a Review].
Bräutigam M; Biskup E
Praxis (Bern 1994); 2018 Jul; 107(14):749-754. PubMed ID: 29969971
[TBL] [Abstract][Full Text] [Related]
5. A case of type I cryoglobulinaemia vasculitis associated with monoclonal gammopathy of undetermined significance exacerbated by a progression to multiple myeloma.
Hng M; Liam CC; Chew TK
QJM; 2022 Aug; 115(8):551-552. PubMed ID: 35482531
[No Abstract] [Full Text] [Related]
6. Monoclonal Gammopathy of Renal Significance-A Rare Renal Presentation: A Review of Cases Reported.
Kichloo A; Nawaz N; Singh J; Aljadah M; Albosta MS; Bhanot R
J Investig Med High Impact Case Rep; 2020; 8():2324709620940500. PubMed ID: 32643956
[TBL] [Abstract][Full Text] [Related]
7. [Thoracic changes in multiple myeloma and monoclonal gammopathy].
Załeska J; Figura-Chojak E; Lesiak B; Wasowska H
Pneumonol Pol; 1985; 53(11-12):546-53. PubMed ID: 3834409
[No Abstract] [Full Text] [Related]
8. A case study progression to multiple myeloma.
Yancey MA; Waxman AJ; Landgren O
Clin J Oncol Nurs; 2010 Aug; 14(4):419-22. PubMed ID: 20682498
[TBL] [Abstract][Full Text] [Related]
9. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V
Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
11. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Nador G; Ramasamy K; Panitsas F; Pratt G; Sadler R; Javaid MK
Rheumatology (Oxford); 2019 Jul; 58(7):1142-1153. PubMed ID: 31225884
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism and monoclonal gammopathy.
Rao DS; Antonelli R; Kane KR; Kuhn JE; Hetnal C
Henry Ford Hosp Med J; 1991; 39(1):41-4. PubMed ID: 1856101
[TBL] [Abstract][Full Text] [Related]
13. [Evolution into indolent myeloma in a patient with benign monoclonal gammopathy after an eleven-year-interval].
Shimizu K; Katoh H; Hirano M
Rinsho Ketsueki; 1988 Apr; 29(4):550-3. PubMed ID: 3404669
[No Abstract] [Full Text] [Related]
14. [Differential diagnoses of osteoporosis].
Stumpf U; Hesse E; Böcker W; Kammerlander C; Neuerburg C; Schmidmaier R
Z Gerontol Geriatr; 2019 Aug; 52(5):414-420. PubMed ID: 31297588
[TBL] [Abstract][Full Text] [Related]
15. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
Go RS; Gundrum JD; Neuner JM
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
